GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Shares Outstanding (EOP)

Eurofins Scientific SE (Eurofins Scientific SE) Shares Outstanding (EOP) : 192 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Eurofins Scientific SE's shares outstanding for the quarter that ended in Dec. 2023 was 192 Mil.

Eurofins Scientific SE's quarterly shares outstanding declined from Jun. 2023 (192 Mil) to Dec. 2023 (192 Mil). It means Eurofins Scientific SE bought back shares from Jun. 2023 to Dec. 2023 .

Eurofins Scientific SE's annual shares outstanding declined from Dec. 2022 (193 Mil) to Dec. 2023 (192 Mil). It means Eurofins Scientific SE bought back shares from Dec. 2022 to Dec. 2023 .


Eurofins Scientific SE Shares Outstanding (EOP) Historical Data

The historical data trend for Eurofins Scientific SE's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Shares Outstanding (EOP) Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.04 190.79 192.25 192.52 192.03

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.25 192.34 192.52 192.19 192.03

Competitive Comparison of Eurofins Scientific SE's Shares Outstanding (EOP)

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Shares Outstanding (EOP) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Shares Outstanding (EOP) falls into.



Eurofins Scientific SE Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Eurofins Scientific SE  (OTCPK:ERFSF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Eurofins Scientific SE Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (Eurofins Scientific SE) Headlines

From GuruFocus

Ruane Cunniff Comments on Eurofins Scientific

By Sydnee Gatewood Sydnee Gatewood 01-24-2020